The Trump administration has removed 11 guidance documents that helped businesses follow the Americans with Disabilities Act.

Thirty-five percent of Americans surveyed said they are unable to access affordable, quality health care when needed.

The MACE risk associated with initiating ustekinumab is comparable to that of adalimumab, etanercept, and secukinumab in patients with PsO or PsA.

US Health Secretary Robert F Kennedy Jr says he will tell the CDC to stop recommending fluoride in drinking water across the country.

US thyroid cancer diagnoses rose from 1975 to 2009 and have plateaued since then, with higher net drift of cancer diagnoses among women.

Topline data were announced from a phase 3 trial evaluating setmelanotide for the treatment of acquired hypothalamic obesity.

A scientific statement regarding the diagnosis and management of blood culture-negative endocarditis has been published by the AHA.

The US Senate has confirmed the appointment of Mehmet Oz, MD, to head the Centers for Medicare & Medicaid Services.

Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.

Federal cuts to funding could “decimate” medical research in the United States, delaying cures and costing countless lives.

The FDA has approved Vykat XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years ...

For patients with inadequately controlled T2D receiving dulaglutide, switching to tirzepatide is associated with additional HbA1c reduction and weight loss.